Changzhou Ruiming Pharmaceutical Co.,Ltd
API | Série intermédiaire | Autres séries intermédiaires--Changzhou Ruiming Pharmaceutical Co., Ltd.
Changzhou Ruiming Pharmaceutical Co., Ltd. est principalement engagée dans la recherche, le développement, la production et la vente de matières premières et de produits intermédiaires pharmaceutiques. Ses principaux produits comprennent le bésylate d'amlodipine, la félodipine, le maléate d'amlodipine, le chlorhydrate de tamsulosine, la base d'amlodipine, etc.
- Type
- Manufacturer
- Location
- Changzhou, Jiangsu, China
- Website
- https://www.chengnanchem.com
- Categories
- Production pharmaceutique, Produits chimiques et plastiques
Listed in a source registry
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- lei-lapsed (amber), checked 2026-08-08 GLEIF
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- gmp-certified (green), checked 2023-11-15 EudraGMDP, EU register of GMP certificates (EMA)
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Chemical substances imported into the EU above 1 tonne/year must be REACH-registered. ECHA (REACH)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)